Does dobutamine reduce infarction severity and improve cardiac oxygen balance in a canine model of LAD narrowing?
In a canine model of coronary narrowing, prompt dobutamine infusion prevented myocardial infarction by improving regional blood flow and oxygen balance without causing excessive chronotropic or vascular effects.
We compared the acute effects of dobutamine and isoproterenol on cardiac O, balance and regional blood flow (studied with microspheres) in eight male beagles with a narrowed left anterior descending coronary artery (LAD). The two drugs similarly increased cardiac contractility, output, and oxygen consumption. However, unlike isoproterenol, dobutamine did not accelerate heart rate or markedly lower peripheral resistance. Also unlike isoproterenol, dobutamine augmented blood flow in regions supplied by the LAD and improved oxygen balance, as indicated by significant increases in coronary sinus Po 2 , oxygen supply-consumption ratio, and lactic acid consumption. To determine whether dobutamine would contain infarction, we continuously infused it or saline in 24 beagles for 24 hours immediately after LAD constriction. Then, 1-3 days after LAD constriction, we assessed the infarction. In 11 of 12 dogs treated with dobutamine, infarctions could not be detected by gross examination or the distribution of microspheres, and microscopic lesions were minimal. In contrast, 10 of 12 dogs treated with saline had gross transmural infarctions, an absence of microspheres in the region supplied by the LAD, and marked microscopic damage. Therefore, prompt and persistent treatment with a powerful inotropic agent, used at doses low enough to avoid chronotropic and vascular side effects, may contain rather than extend myocardial infarction by increasing the supply of oxygen more than it increases the requirement for oxygen.
Tuttle et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: